Sleep, cognition & neuro
Cerebrolysin
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.
A porcine-brain-derived peptide preparation used clinically in some countries for stroke and dementia.
What it is
Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from pig brain tissue, approved and used in parts of Europe and Asia for ischemic stroke and dementia. It is not approved in the United States.
What it's studied for
- Functional recovery after ischemic stroke
- Cognition in vascular and Alzheimer's dementia
- Traumatic brain injury recovery
How it's used in practice
- Administered in clinical courses under supervision where it is approved
- Trial results are mixed and effect sizes are debated
What you should know before asking about it
- Not FDA-approved in the United States
- Biologic derived from animal tissue — sourcing and quality matter enormously
- Not something to source or self-administer outside a medical setting
Frequently asked questions.
- What is Cerebrolysin?
- Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from pig brain tissue, approved and used in parts of Europe and Asia for ischemic stroke and dementia. It is not approved in the United States.
- What is Cerebrolysin studied for?
- Published and ongoing research looks at functional recovery after ischemic stroke; cognition in vascular and Alzheimer's dementia; traumatic brain injury recovery. These are areas of study, not promised outcomes.
- Is Cerebrolysin FDA-approved?
- Cerebrolysin has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
- How is Cerebrolysin typically used?
- Administered in clinical courses under supervision where it is approved Trial results are mixed and effect sizes are debated Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
- What are the risks and unknowns with Cerebrolysin?
- Not FDA-approved in the United States Biologic derived from animal tissue — sourcing and quality matter enormously Not something to source or self-administer outside a medical setting
Sources
- 1.Published literature on Cerebrolysin— PubMed, U.S. National Library of Medicine
- 2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
- 3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
- 4.Test directory and patient service center locator— Quest Diagnostics
About this page
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.
This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.
More in Sleep, cognition & neuro
DSIP
A neuropeptide studied for its effect on slow-wave sleep architecture and stress response.
Selank
A synthetic analog of the immunopeptide tuftsin studied for anxiolytic and stress-response effects.
Semax
An ACTH(4-10) analog studied for attention, memory and neuroprotection.